Yes, they posted it today. NP said at the end they are still in fund raising mode. They don't have enough to go all the way to commercial product. So I guess a partnership is still up in the air. Really they need enough money to finish the BLA, after that they should get a nice bump.

Nice mice model discussion. No mouse on leronlimab had the cancer metastasized. Also they are going to treat the placebo mice to see if they can be recovered, which is a great idea. My previous suspicion is the early the better, but it will be nice to see what happens at when starting at a very late stage.. With the TNBC study, they didn't require ctc>5 like other trials using ctc numbers, that increased the likelihood of success here in my opinion.

I checked to make sure that background poster behind NP was not the new poster for next week, but alas it was from last year.

https://www.youtube.com/watch?v=qh5dH7_vvWc